CARDIAC SCIENCE INC 4

4 · CARDIAC SCIENCE INC · Filed Sep 1, 2005

Form 4

Period: 2005-09-01

Chief Product Develop. Officer

Transactions

Disposition to Issuer
NON-QUALIFIED STOCK OPTION (RIGHT TO BUY)
2005-09-01−125,000→ 0 total
Exercise: $2.06From: 2002-09-21Exp: 2011-09-21→ COMMON STOCK (125,000 underlying)
Disposition to Issuer
NON-QUALIFIED STOCK OPTION (RIGHT TO BUY)
2005-09-01−150,000→ 0 total
Exercise: $4.00From: 2001-05-18Exp: 2010-05-18→ COMMON STOCK (150,000 underlying)
Disposition to Issuer
NON-QUALIFIED STOCK OPTION (RIGHT TO BUY)
2005-09-01−30,000→ 0 total
Exercise: $1.75From: 2003-10-24Exp: 2012-10-24→ COMMON STOCK (30,000 underlying)
Disposition to Issuer
NON-QUALIFIED STOCK OPTION (RIGHT TO BUY)
2005-09-01−40,000→ 0 total
Exercise: $3.99From: 2004-12-31Exp: 2013-12-31→ COMMON STOCK (40,000 underlying)

Footnotes (4)

[F1]The vesting of this option fully accelerated and was assumed by CSQ Holding Company in the merger between the issuer and a wholly-owned subsidiary of CSQ Holding Company (the "Merger") and replaced with an option to purchase 4,000 shares of CSQ Holding Company for $39.90 per share.
[F2]The vesting of this option fully accelerated and was assumed by CSQ Holding Company in the Merger and replaced with an option to purchase 3,000 shares of CSQ Holding Company common stock for $17.50 per share.
[F3]The vesting of this option fully accelerated and was assumed by CSQ Holding Company in the Merger and replaced with an option to purchase 12,500 shares of CSQ Holding Company common stock for $20.60 per share.
[F4]The vesting of this option fully accelerated and was assumed by CSQ Holding Company in the Merger and replaced with an option to purchase 15,000 shares of CSQ Holding Company common stock for $40.00 per share

Documents

1 file